Its approach gives clients a clearer path from clinical batches to commercial readiness. Project oversight, quality systems and technical support work within one delivery structure, helping teams track batch progress, release requirements and validation milestones without splitting responsibility across multiple vendors.Integrated Manufacturing and Regulatory Coordination
Jubilant HollisterStier supports clients through sterile fill-finish, lyophilization, inspection and packaging, along with analytical testing, cold-chain capabilities and regulatory assistance. Its Spokane and Montreal facilities handle injectable products for regulated markets while keeping manufacturing, quality and technical teams closely aligned. This reduces delays that often occur when different vendors manage separate parts of the manufacturing cycle.
The company’s regulatory strength comes from everyday inspection readiness. Quality oversight, documentation discipline and validated manufacturing processes are built into production workflows instead of being treated as separate compliance steps. This approach helped the company receive zero observations during a recent FDA inspection conducted by the Center for Biologics Evaluation and Research.
Project execution continues beyond delivery into long-term manufacturing continuity. Jubilant HollisterStier’s 92 percent customer return rate underscores the confidence clients place in its delivery discipline, communication structure and ability to support additional projects over time. Clients receive ongoing updates regarding production status, quality milestones and release timelines, allowing development teams to respond faster to manufacturing or submission requirements.
Scaling Fill-Finish Reliability Across Global Markets
Jubilant HollisterStier’s service model extends beyond manufacturing throughput into lifecycle management support that addresses packaging, serialization and inspection requirements tied to regulated pharmaceutical distribution. Automated visual inspection systems, secondary packaging capabilities and cold-storage management allow products to move through later commercialization stages without fragmented vendor coordination.
Its fill-finish infrastructure also supports pharmaceutical companies managing sensitive biologics and injectable therapies requiring specialized environmental controls. Advanced lyophilizers equipped with automated integration systems, clean-in-place technology and controlled shelf loading conditions help maintain product stability during freeze-drying processes. That capability becomes increasingly important for biologics manufacturers balancing scalability with strict product handling requirements.
The company’s partnership structure places strong emphasis on direct collaboration during product transfer, qualification and scale-up activities. Technical services, supply chain teams and manufacturing groups remain involved throughout implementation stages to address production adjustments and validation requirements quickly.
Leadership continues investing in workforce readiness and manufacturing continuity. Jubilant HollisterStier partnered with Spokane Colleges to launch a biomanufacturing certification initiative designed to strengthen regional manufacturing talent pipelines. Internal expansion efforts across engineering, commercial operations and quality functions further support the company’s long-term manufacturing roadmap as demand for sterile injectables continues rising globally.
Recognition as one of the Top 10 Regulatory Service Providers 2026 reflects Jubilant HollisterStier’s ability to combine manufacturing precision, inspection readiness and coordinated regulatory support inside one integrated delivery framework. Jubilant HollisterStier distinguishes itself through disciplined execution, scalable fill-finish infrastructure and a client-focused manufacturing model that helps pharmaceutical companies move products forward with greater reliability, consistency and regulatory confidence.
